Company
About us
History
Leaderships
Team
EU grants
Requests for Proposal
Sustainability – ESG
Bussines strategy
Quality policy
Virtual Tour
Investors
Corporate documents
Shareholders and shares
Periodic reports
Current reports
Sustainability reports
Corporate governance at Mabion
Financial data
For Investors
Calendar
Resources
Science Hub
Press releases
News
Events
Media kit
Services
Process Development
Analytics
Drug Substance Manufacturing
Contact
Contact form
Contact for investors
Contact for media
Careers
Science News
Resources
Manufacturing
Bioprocess Optimization Across Upstream and Downstream Processing
Drug development
,
Drug product
,
Drug substance
,
Manufacturing
Meeting Global Regulatory Standards in Biologic Drug Manufacturing Projects
Biologics
,
EMA
,
FDA
,
GMP
,
Mabion
,
Manufacturing
,
Regulatory
Tailoring Cell Line Development for Efficient Biologics Process Outcomes
Biologics
,
Drug development
,
GMP
,
Manufacturing
GMP Biologics Manufacturing in End-to-End Drug Development
Biologics
,
Drug development
,
GMP
,
Manufacturing
Strategies for High-Quality Recombinant Protein Production
Manufacturing
,
Proteins
Poster
Integrated Modeling of Upstream and Downstream Bioprocessing to Improve Biologics Production Efficiency
Biologics
,
Drug development
,
Mabion
,
Manufacturing
Therapeutic Protein Production in Modern Biologic Medicines
Manufacturing
,
Proteins
EU GMP Annex 1 – Sterile Manufacturing Requirements and Controls
Contamination
,
Manufacturing
,
Regulatory
ADC Manufacturing – A Comprehensive Guide to Drug Substance Manufacturing Services
Antibody-drug conjugates
,
GMP
,
Manufacturing
1
2
…
4
Next